Bellevue Life Sc Stock Price, News & Analysis
BLACU
NASDAQ
Company Description
Bellevue Life Sciences Acquisition Corp (BLACU) is a blank check company that has recently entered into a business combination agreement with OSR Holdings Co., Ltd. Following the transaction, OSR Holdings will become a subsidiary of BLAC and will focus on developing innovative biomedical therapies. OSR Holdings operates in the biopharmaceutical and medical device sectors with subsidiaries including Vaximm for cancer immunotherapy, Darnatein for osteoarthritis treatment, and RMC for medical device distribution. The business combination aims to enhance OSR Holdings' global presence in the healthcare industry by leveraging BLAC's resources and expertise.
Stock Performance
$—
0.00%
0.00
Last updated:
-68.69 %
Performance 1 year
$0.0
Market Cap
6.4M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Bellevue Life Sc.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the current stock price of Bellevue Life Sc (BLACU)?
The current stock price of Bellevue Life Sc (BLACU) is $3.36 as of February 14, 2025.
What is Bellevue Life Sciences Acquisition Corp (BLACU)?
BLACU is a blank check company that has recently entered into a business combination agreement with OSR Holdings Co., Ltd. to focus on developing innovative biomedical therapies.
What is the goal of the business combination between BLACU and OSR Holdings?
The goal is for OSR Holdings to become a subsidiary of BLACU, leveraging BLACU's resources and expertise to enhance OSR Holdings' global presence in the healthcare industry.
What sectors does OSR Holdings operate in?
OSR Holdings operates in the biopharmaceutical and medical device sectors with subsidiaries including Vaximm for cancer immunotherapy, Darnatein for osteoarthritis treatment, and RMC for medical device distribution.
Who are the key executives involved in the business combination agreement?
Sung Jae Yu, Chief Operating Officer of OSR Holdings, and Kuk Hyoun Hwang, CEO of BLACU, are key executives involved in the agreement.